why choose us

First received: August 24, 2023

Clinical Trial: A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Non-Small Cell Lung Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Open-label, Randomized, Multi-arm Study of BGB-A445 in Combination With Investigational Agents in Non-Small Cell Lung Cancer Patients Previously Treated With Anti-PD-(L)1 Antibody

Brief Summary: The main objective of this study is to evaluate the anti-tumor activity of BGB-A445 plus investigational agents in participants with non-small cell lung cancer (NSCLC)

Read more